About Iris
Iris Yang focuses her practice on capital markets transactions, representing issuers and investment banks in initial public offerings in Hong Kong and US.
Iris received her LLM from the University of Hong Kong, and her LLB from Zhejiang University.
Representative Matters
Capital Markets
- Summit Healthcare Acquisition Corp., a SPAC, in its $849 million merger with YS Biopharma, a leading international biotech company
- Joint sponsors and underwriters Citi and Huatai International on Cryofocus Medtech's HK$210 million IPO and listing on HKEX